HAMSAB Diet Ameliorates Dysfunctional Signaling in Pancreatic Islets in Autoimmune Diabetes
Overview
Authors
Affiliations
An altered gut microbiota is associated with type 1 diabetes (T1D), affecting the production of short-chain fatty acids (SCFA) and glucose homeostasis. We previously demonstrated that enhancing serum acetate and butyrate using a dietary supplement (HAMSAB) improved glycemia in non-obese diabetic (NOD) mice and patients with established T1D. The effects of SCFA on immune-infiltrated islet cells remain to be clarified. Here, we performed single-cell RNA sequencing on islet cells from NOD mice fed an HAMSAB or control diet. HAMSAB induced a regulatory gene expression profile in pancreas-infiltrated immune cells. Moreover, HAMSAB maintained the expression of β-cell functional genes and decreased cellular stress. HAMSAB-fed mice showed preserved pancreatic endocrine cell identity, evaluated by decreased numbers of poly-hormonal cells. Finally, SCFA increased insulin levels in human β-like cells and improved transplantation outcome in NOD/SCID mice. Our findings support the use of metabolite-based diet as attractive approach to improve glucose control in T1D.
From Microbes to Metabolites: Advances in Gut Microbiome Research in Type 1 Diabetes.
Blok L, Hanssen N, Nieuwdorp M, Rampanelli E Metabolites. 2025; 15(2).
PMID: 39997763 PMC: 11857261. DOI: 10.3390/metabo15020138.
Mostafavi Abdolmaleky H, Zhou J Antioxidants (Basel). 2024; 13(8).
PMID: 39199231 PMC: 11351922. DOI: 10.3390/antiox13080985.
Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment.
Gojani E, Rai S, Norouzkhani F, Shujat S, Wang B, Li D Curr Issues Mol Biol. 2024; 46(7):7621-7667.
PMID: 39057094 PMC: 11275945. DOI: 10.3390/cimb46070453.
Ni M, He H, Chen M, Li Z, Cai H, Chen Z J Anim Sci. 2024; 102.
PMID: 39037212 PMC: 11337008. DOI: 10.1093/jas/skae197.